122 related articles for article (PubMed ID: 16806408)
1. Decreased nitric oxide and increased platelet aggregation levels in patients with Behçet's disease.
Yapişlar H; Aydogan S; Borlu M; Ascioglu O
Thromb Res; 2007; 119(4):461-5. PubMed ID: 16806408
[No Abstract] [Full Text] [Related]
2. Lipoprotein (a) and nitrites in Behcet's disease: relationship with disease activity and vascular complications.
Esmat S; El Sherif H; Anwar S; Fahmy I; Elmenyawi M; Shaker O
Eur J Dermatol; 2006; 16(1):67-71. PubMed ID: 16436346
[TBL] [Abstract][Full Text] [Related]
3. The levels of serum neopterin in Behçet's disease--objective marker of disease activity.
Köse O; Arca E; Akgül O; Erbil K
J Dermatol Sci; 2006 May; 42(2):128-30. PubMed ID: 16600572
[No Abstract] [Full Text] [Related]
4. Decreased nitric oxide production in patients with Behçet's disease.
Orem A; Vanizor B; Cimşit G; Kiran E; Değer O; Malkoç M
Dermatology; 1999; 198(1):33-6. PubMed ID: 10026399
[TBL] [Abstract][Full Text] [Related]
5. [Platelet function in patients with Alzheimer disease: analysis of 40 cases].
Yu J; Jia JP
Zhonghua Yi Xue Za Zhi; 2009 Jan; 89(3):183-6. PubMed ID: 19537035
[TBL] [Abstract][Full Text] [Related]
6. Vitamin levels in Behçet's disease.
Kandi B; Cicek D; Ilhan N
J Dermatolog Treat; 2007; 18(2):69-75. PubMed ID: 17520462
[TBL] [Abstract][Full Text] [Related]
7. Serum iron and ferritin levels in Behçet's disease.
Gonul M; Gul U; Cakmak SK; Soylu S; Kilic A
Indian J Dermatol Venereol Leprol; 2010; 76(1):85. PubMed ID: 20061748
[No Abstract] [Full Text] [Related]
8. Circulated activated platelets and increased platelet reactivity in patients with Behçet's disease.
Akar S; Ozcan MA; Ateş H; Gürler O; Alacacioglu I; Ozsan GH; Akkoç N; Ozkan S; Demirkan F; Onen F
Clin Appl Thromb Hemost; 2006 Oct; 12(4):451-7. PubMed ID: 17000890
[TBL] [Abstract][Full Text] [Related]
9. Platelet activation and red blood cell phosphatidylserine exposure evaluated by flow cytometry in patients with Behçet's disease: are they related to thrombotic events?
Martínez M; Ricart JM; Ruiz-Aja S; Rus A; Todolí J; Calvo J; Vayá A
Pathophysiol Haemost Thromb; 2007; 36(1):18-22. PubMed ID: 18332610
[TBL] [Abstract][Full Text] [Related]
10. Oxidative stress in patients with Behcet's disease: I correlation with severity and clinical parameters.
Najim RA; Sharquie KE; Abu-Raghif AR
J Dermatol; 2007 May; 34(5):308-14. PubMed ID: 17408439
[TBL] [Abstract][Full Text] [Related]
11. [A case of incomplete vasculo-Behçet's disease associated with hereditary abnormal plasminogenemia].
Tabuchi M; Suzuki S; Yamada H; Horiuti T; Nakazima K; Miyamoto T
Nihon Naika Gakkai Zasshi; 1986 Dec; 75(12):1799-804. PubMed ID: 3559353
[No Abstract] [Full Text] [Related]
12. Serum neopterin levels in Behçet's syndrome.
Keser G; Oksel F; Aksu K; Kabasakal Y; Gümüşdiş G; Doganavş argil E; Sin A
Clin Rheumatol; 2000; 19(4):328-9. PubMed ID: 10941821
[No Abstract] [Full Text] [Related]
13. Homocysteine: an activity marker in Behçet's disease?
Sarican T; Ayabakan H; Turkmen S; Kalaslioglu V; Baran F; Yenice N
J Dermatol Sci; 2007 Feb; 45(2):121-6. PubMed ID: 17182219
[TBL] [Abstract][Full Text] [Related]
14. Oxidases and oxygenases in regulation of neutrophil redox pathways in Behçet's disease patients.
Melikoglu MA; Kacar C; Cort A; Yucel G; Aslan M
J Enzyme Inhib Med Chem; 2012 Feb; 27(1):12-7. PubMed ID: 21699462
[TBL] [Abstract][Full Text] [Related]
15. The pathophysiological significance of red blood cell nitric oxide concentrations in inflammatory Behçet's disease.
Evereklioglu C; Cekmen M; Ozkiriş A; Karabaş L; Caliş M
Mediators Inflamm; 2003 Aug; 12(4):255-6. PubMed ID: 14514478
[No Abstract] [Full Text] [Related]
16. Plasma endothelin-1 levels before and after vascular occlusive test in patients with Behçet's disease.
Cimsit G; Karahan SC; Orem A; Vanizor B; Alpay K
Australas J Dermatol; 2001 Aug; 42(3):221-2. PubMed ID: 11510468
[No Abstract] [Full Text] [Related]
17. Dengue fever activates the L-arginine-nitric oxide pathway: an explanation for reduced aggregation of human platelets.
Mendes-Ribeiro AC; Moss MB; Siqueira MA; Moraes TL; Ellory JC; Mann GE; Brunini TM
Clin Exp Pharmacol Physiol; 2008 Oct; 35(10):1143-6. PubMed ID: 18505438
[TBL] [Abstract][Full Text] [Related]
18. Platelet function, blood coagulation and fibrinolysis in Behcet's syndrome.
Stathakis NE; Economopoulos TC; Papayannis AG; Thomopoulos D
Blut; 1977 Mar; 34(3):215-22. PubMed ID: 843627
[TBL] [Abstract][Full Text] [Related]
19. Serum and erythrocyte adenosine deaminase activities in patients with Behçet's disease.
Canpolat F; Unver M; Eskioğlu F; Kösebalaban S; Durmazlar SP
Int J Dermatol; 2006 Sep; 45(9):1053-6. PubMed ID: 16961545
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide levels in Behçet's disease.
Sancak B; Onder M; Oztas MO; Bukan N; Gürer MA
J Eur Acad Dermatol Venereol; 2003 Jan; 17(1):7-9. PubMed ID: 12602959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
